Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) announced a dividend on Tuesday, January 14th, NASDAQ Dividends reports. Shareholders of record on Friday, March 7th will be given a dividend of 0.1072 per share on Thursday, March 27th. The ex-dividend date of this dividend is Friday, March 7th.
Elekta AB (publ) Stock Down 4.0 %
Shares of EKTAY stock traded down $0.23 during trading hours on Friday, reaching $5.51. 10,805 shares of the company's stock were exchanged, compared to its average volume of 9,384. The stock's 50 day moving average is $5.75 and its 200-day moving average is $6.04. The company has a market cap of $2.11 billion, a price-to-earnings ratio of 22.04 and a beta of 1.25. The company has a current ratio of 1.05, a quick ratio of 0.81 and a debt-to-equity ratio of 0.60. Elekta AB has a fifty-two week low of $5.25 and a fifty-two week high of $8.24.
Elekta AB (publ) (OTCMKTS:EKTAY - Get Free Report) last issued its quarterly earnings results on Friday, February 21st. The company reported $0.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.09 by ($0.01). The business had revenue of $416.86 million for the quarter, compared to analyst estimates of $435.89 million. Elekta AB (publ) had a return on equity of 11.07% and a net margin of 5.65%. Analysts predict that Elekta AB will post 0.36 earnings per share for the current fiscal year.
Analysts Set New Price Targets
Separately, Sanford C. Bernstein raised Elekta AB (publ) from a "strong sell" rating to a "hold" rating in a research report on Wednesday, January 29th.
View Our Latest Research Report on Elekta AB (publ)
About Elekta AB (publ)
(
Get Free Report)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.
See Also

Before you consider Elekta AB (publ), you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Elekta AB (publ) wasn't on the list.
While Elekta AB (publ) currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.